Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-03-01
2011-03-01
Stockton, Laura L. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S496000, C514S419000
Reexamination Certificate
active
07897788
ABSTRACT:
The invention relates to indol-1-yl-acetic acid derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and methods of treatment comprising administration of said compounds.
REFERENCES:
patent: 2001/0039286 (2001-11-01), Dinnell et al.
patent: 2003/0158153 (2003-08-01), Menta et al.
patent: 2005/0014942 (2005-01-01), Maruyama et al.
patent: WO 95/07294 (1995-03-01), None
patent: WO-03/037862 (2003-05-01), None
patent: WO 03/101981 (2003-12-01), None
patent: WO 2005/054232 (2005-06-01), None
Chemical Abstracts Registry No. 347911-97-1, entry date into the Registry file on STN is Jul. 24, 2001.
Souillac, et al., Characterization of Delivery Systems, Differential Scanning Calorimetry in Encyclopedia of Controlled Drug Delivery, 1999, John Wiley & Sons, pp. 212-227.
Vippagunta et al. (Advanced Drug Delivery Reviews, 48 (2001), pp. 3-26.
Doan et al., Journal of Clinical Pharmacology, 2005, 45, pp. 751-762.
Barnes et al., European Respiratory Journal, 2005, 25, pp. 1084-1105.
Philip L. Gould., International Journal of Pharmaceutics, vol. 33, pp. 201-217 (1986).
Warawa et al., J. Med. Chem., vol. 44, pp. 372-389 (2001).
Gastpar et al., J. Med. Chem., vol. 41, pp. 4965-4972 (1998).
Richard C. Larock et al., “Comprehensive Organic Transformations: A Guide to Functional Group Preparations”, Wiley-VCH publishers, Second Edition (1999).
Berge et al., Journal of Pharmaceutical Sciences, vol. 66, pp. 1-19 (1977).
Sawyer et al., British Journal of Pharmacology, vol. 137, pp. 1163-1172 (2002).
Sugimoto et al., The Journal of Pharmacology and Experimental Therapeutics, vol. 305, No. 1, pp. 347-352 (2003).
Hans Bundgaard, “Design of Prodrugs”, Elsevier, pp. 7-9, 21-24 (1985).
Moriya et al., Chem. Pharm. Bull., vol. 28, No. 6, pp. 1711-1721 (1980).
R.B. Silverman, The Organic Chemistry of Drug Design and Drug Action, Academic Press, San Diego, CA, U.S.A., pp. 352-401, (1992).
Hata et al., Molecular Pharmacology, vol. 67, pp. 640-647 (2005).
“The Use of indole-3-acetic acids as CRTH2 receptor antagonists”, Expert Opin. Ther. Patents, vol. 14, No. 1, pp. 125-128 (2004).
Fecher Anja
Fretz Heinz
Hilpert Kurt
Riederer Markus
Actelion Pharmaceutical Ltd.
Hunton & Williams LLP
Stockton Laura L.
LandOfFree
Indol-1-yl-acetic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indol-1-yl-acetic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indol-1-yl-acetic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2701883